P
Petra Olivova
Researcher at Waters Corporation
Publications - 7
Citations - 1355
Petra Olivova is an academic researcher from Waters Corporation. The author has contributed to research in topics: Two-dimensional chromatography & Mass spectrometry. The author has an hindex of 5, co-authored 6 publications receiving 1268 citations.
Papers
More filters
Journal ArticleDOI
Orthogonality of separation in two-dimensional liquid chromatography.
TL;DR: The RP-RP system (employing significantly different pH in both RP separation dimensions) had the highest practical peak capacity of 2D-LC systems investigated and was found to provide suitable orthogonality.
Journal ArticleDOI
Two‐dimensional separation of peptides using RP‐RP‐HPLC system with different pH in first and second separation dimensions
TL;DR: The orthogonality of 2D separation was investigated for selected types of RP stationary phases, ion-pairing agents and mobile phase pH; the pH appears to have the most significant impact on the RP-LC separation selectivity.
Journal ArticleDOI
Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flight mass spectrometry.
TL;DR: An improved analytical method for glycosylation structural characterizations of a monoclonal antibody (mAb) using a newly developed quadrupole ion-mobility time-of-flight (ESI-Q-IM-TOF) mass spectrometer is presented.
Journal ArticleDOI
Comparison of 1‐D and 2‐D LC MS/MS methods for proteomic analysis of human serum
Martin Gilar,Petra Olivova,Asish B. Chakraborty,Aleksander Jaworski,Scott J. Geromanos,John C. Gebler +5 more
TL;DR: 1‐D and 2‐D LC methods were utilized for proteome analysis of undepleted human serum and the performance of both methods for proteomic analysis is critically compared.
Journal ArticleDOI
Peptide retention prediction applied to proteomic data analysis
TL;DR: A retention prediction model was developed for peptides separated in reversed-phase chromatography and utilized to identify and exclude the false positive peptide identifications obtained via database search.